The Net Margin of Polus BioPharm Inc (007630.KS) is -66.65%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2020-12-31 | -66.65% |
2019-12-31 | -139.80% |
2018-12-31 | -239.62% |
2017-12-31 | -10.02% |
2016-12-31 | -54.70% |
2015-12-31 | -22.43% |
2014-12-31 | 1.95% |
2013-12-31 | -24.61% |
2012-12-31 | 1.09% |
2011-12-31 | -17.80% |